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Abstract
Background: The initial steps of stem Leydig cell differentiation into steroid producing progenitor cells
are thought to take place independent of luteinizing hormone (LH), under the influence of locally produced
factors such as leukaemia inhibitory factor (LIF), platelet derived growth factor A and stem cell factor. For
the formation of a normal sized Leydig cell population in the adult testis, the presence of LH appears to
be essential.
Oncostatin M (OSM) is a multifunctional cytokine and member of the interleukin (IL)-6 family that also
includes other cytokines such as LIF. In the rat OSM is highly expressed in the late fetal and neonatal testis,
and may thus be a candidate factor involved in Leydig cell progenitor formation.
Methods: Interstitial cells were isolated from 13-day-old rat testes and cultured for 1, 3 or 8 days in the
presence of different doses of OSM (range: 0.01 to 10 ng/ml) alone or in combination with LH (1 ng/ml).
The effects of OSM and LH on cell proliferation were determined by incubating the cultures with
[3H]thymidine or bromodeoxyuridine (BrdU). Developing progenitor cells were identified histochemically
by the presence of the marker enzyme 3beta-hydroxysteroid dehydrogenase (3beta-HSD).
Results: OSM, when added at a dose of 10 ng/ml, caused a nearly 2-fold increase in the percentage of
Leydig cell progenitors after 8 days of culture. Immunohistochemical double labelling experiments with
3beta-HSD and BrdU antibodies showed that this increase was the result of differentiation of stem Leydig
cells/precursor cells and not caused by proliferation of progenitor cells themselves. The addition of LH to
the cultures consistently resulted in an increase in progenitor formation throughout the culture period.
Surprisingly, when OSM and LH were added together, the LH induced rise in progenitor cells was
significantly inhibited after 3 and 8 days of culture.
Conclusion: Taken together, the results of the present study suggest that locally produced OSM may not
only play a role in the regulation of Sertoli cell proliferation and the initiation of spermatogenesis but may
also play a role in the regulation of Leydig cell progenitor formation by keeping the augmenting effects of
LH on this process in abeyance.
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In the rat two defined periods of proliferation and differ-
entiation of Leydig cells can be discerned. The first wave
occurs during fetal life and gives rise to the fetal-type pop-
ulation of Leydig cells, while the second wave is initiated
during the (pre)pubertal period and results in the forma-
tion of the mature adult-type Leydig cell population [1-3].
Between days 14 and 21 after birth the number of fetal-
type Leydig cells starts to decrease, although 50 to 75% of
the fetal-type Leydig cells present at the time of birth per-
sist in the adult testis [4]. The second generation of Leydig
cells, the so-called adult-type Leydig cells, develops from
stem Leydig cells through several steps of differentiation
and proliferation during (pre)puberty [2,3,5-8]. Spindle-
shaped stem Leydig cells of mesenchymal origin, identi-
fied by the presence of platelet derived growth factor
receptor α (PDGFR-α), leukemia inhibitory factor (LIF)
receptor and c-kit, and the absence of LH receptors and
steroidogenic enzyme expression, are thought to differen-
tiate into luteinizing hormone (LH) receptor/3β-
hydroxysteroid dehydrogenase (3β-HSD) positive Leydig
cell progenitors between days 10 and 13 after birth. These
progenitors undergo a wave of proliferation and differen-
tiation and become immature adult-type Leydig cells
between days 28 and 35 after birth. The immature Leydig
cells subsequently differentiate into mature, terminally
differentiated, adult-type Leydig cells. By the end of
puberty the development of the adult population is com-
pleted. Each step in this developmental process is charac-
terized by specific morphological aspects of the
developing cells [3,7,9,10] and the expression of specific
steroidogenic enzymes, such as 5α-reductase, 3β-HSD,
cholesterol side chain cleavage (P450scc) and 17α-hydrox-
ylase (P45017a) [11-13].
A considerable number of studies have been performed to
investigate the regulation of this complicated develop-
mental process in more detail [14-17]. Treatment of hypo-
physectomized prepubertal rats with highly purified LH
has been shown to stimulate both differentiation of stem
Leydig cells/precursor cells and proliferation of the newly
formed progenitor Leydig cells [16]. Similarly, treatment
of prepubertal boys with the luteinizing hormone (LH)
analogue human chorionic gonadotropin (hCG) induces
the formation of new Leydig cells through stem cell/pre-
cursor cell differentiation [15]. The importance of LH in
this developmental process was recently further stressed
in vitro [18]. In this study we showed, using interstitial
cell preparations isolated from 10-, 13- or 18-day-old rat
testes, that Leydig stem cells acquire first LH receptors and
become precursor cells before they differentiate into LH
receptor/3β-HSD positive progenitors. LH appears to be
essential for this differentiation process to proceed, even
at extremely low doses [18] to establish a normal sized
mature Leydig cell population in the adult testis [19].
Although the above studies indicate that LH plays an
important role in the formation of the adult-type Leydig
cell population, there are indications that other factors
may be involved in this process as well. Knockout studies
have shown that in the absence of the Desert hedgehock
(Dhh) gene [20] or platelet-derived growth factor-A
(PDGF-A) [21], progenitor Leydig cell development did
not occur in the prepubertal testis, despite plasma LH lev-
els being normal. Whether these factors exert their effect
on this developmental process alone or together with
other factors, such as members of the interleukin family,
is at present not known.
Oncostatin-M (OSM) is a polypeptide growth factor that
was first identified in humans by its ability to inhibit solid
tumour cell proliferation [22]. Amino acid analysis has
demonstrated that OSM is a member of the interleukin-6
(IL-6) family of cytokines, which includes leukemia
inhibitory factor (LIF), cilliary neurotrophic factor
(CNTF) [23] and IL-11 [24]. All members of this family of
cytokines act through high affinity heterodimer receptors
that share the signal transducing receptor gp130 [25].
OSM mediates its bioactivity through two different het-
erodimer receptors, the type I OSM receptor which con-
sists of a dimer of the gp130 transducing receptor and the
LIF receptor β-subunit, and the type II OSM receptor in
which gp130 has dimerized with the OSM receptor β-sub-
unit [26]. In the rat OSM is highly expressed in the late
fetal and neonatal testis, as well as in the maturing and
adult testis though at a lower level [27]. In vitro studies
have demonstrated that neonatal Sertoli cells produce
OSM and that OSM stimulates Sertoli cell and gonocyte
proliferation [28,29]. Preliminary observations showed
that OSM immunoreactivity was also observed in the
interstitial compartment of the developing testis, presum-
ably in the Leydig cells in both rats [27] and humans [29].
In the present study the possible effects of OSM on the dif-
ferentiation of spindle-shaped stem Leydig cells/precursor
cells into 3β-HSD positive progenitor cells was investi-
gated in more detail. Interstitial cells were isolated from
13-day-old rat testes, an age at which the first Leydig cell
progenitors have just been formed in the sub-strain of
Wistar rats used in this study, and cultured in the presence
of LH and different doses of OSM. Differentiation of cells
into Leydig cell progenitors was assessed by quantifying
the presence of 3β-HSD positive cells under the different
culture conditions. The proliferative activity of the cells
was assessed by 3H-thymidine and BrdU incorporation.
Methods
Isolation of cells
Immature Wistar rats were obtained from the Central Ani-
mal Facilities of Utrecht University (the Netherlands). For
each experiment groups of 20 to 30 animals were killed atPage 2 of 9
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2007, 5:43 http://www.rbej.com/content/5/1/43the age of 13 days by CO2/O2 asphyxiation. For the in vivo
detection of OSM type I receptor/LIF receptor three 13-
day-old rats were used. Following fixation in Bouin's fluid
for 24 h the testes were transferred to 50% ethanol for 24
h after which the testes were stored in 70% ethanol until
embedding in paraffin. All experiments were carried out at
least 3 times.
Interstitial cells were isolated as described by Teerds and
colleagues [18]. In brief, testes were removed, decapsu-
lated and subjected to enzymatic digestion in a shaking
water bath, using 5 mg collagenase (type IV, 213 U/mg;
Worthington Biochemical Corp, Freehold, NJ) in 20 ml
Hanks buffered salt solution (HBSS; Gibco, Life Technol-
ogies, Grand Island, NY). Following enzymatic digestion
HBSS was added until a total volume of 50 ml was
reached and larger tubular fragments were allowed to set-
tle under unit gravity. The supernatant was removed and
smaller fragments and cell clumps were now allowed to
settle. The supernatant was then collected, filtered and
centrifuged. The pellet obtained was resuspended in 2 ml
culture medium consisting of RPMI 1640 supplemented
with penicillin (110 U/ml), streptomycin (100 μg/ml),
0.1% BSA and glutamine (2 mM; all substances were
obtained from Gibco), followed by centrifugation. The
supernatant was centrifuged again and the pellet was also
resuspended in 2 ml culture medium. Both pellets were
pooled. Cells were either seeded in 24-well plates on glass
cover-slips at a density of 150,000 cells per well, or in 96-
well plates at a density of 75,000 cells per well. After 3 h
of culture, the medium was replaced in order to remove
contaminating germ cells after which the cell isolates con-
sisted of myoid cells, spindle-shaped mesenchymal-like
cells, Sertoli cells, fetal-type Leydig cells and very low
numbers of macrophages and Leydig cell progenitors. The
spindle-shaped mesenchymal-like cells which in the testis
can be found in a peritubular as well as a perivascular
localization [3], are considered to be the stem cells/pre-
cursor cells of the Leydig cell progenitors [2,5,8]. The rea-
son why we chose to use a relatively impure interstitial cell
preparation was to include those cell types which have
been shown in vivo to secrete paracrine factors known to
influence the differentiation of stem Leydig cells, such as
the Sertoli cell and peritubular/myoid cell derived growth
factors PDGF A, transforming growth factor α (TGF-α)/
epidermal-like growth factor (EGF), stem cell factor (SCF)
and LIF [8].
Cells were cultured for either 1, 3, or 8 days at 37°C in air
plus 5% CO2 in the presence of either 0 or 1 ng/ml ovine
LH (NIH-LH-S20, Endocrinology Study Section of the
National Institute of Health, Bethesda, MD), 0.01, 0.1, 1
or 10 ng/ml human recombinant OSM (Genzyme, Cam-
bridge, MA), or in the presence of a combination of LH
and different concentrations of OSM. These concentra-
tions of OSM and LH were chosen based on the results of
previous studies [18,27]. The culture medium was
replaced every two days.
The described experiments were approved by the ethical
committee for laboratory animal welfare of the Faculty of
Veterinary Medicine, Utrecht University, Utrecht, the
Netherlands.
Scintillation counting
The effect of LH and OSM on the proliferation of the inter-
stitial cell preparations was determined by incubating the
cell cultures (96 well plates, 75,000 cells/well) with
[3H]thymidine (2 μCi/ml; SA, 0.5 Ci/mmol; Amersham,
Aylesbury, UK). Cells were isolated from 13-day-old rat
testes and cultured for 1, 3 or 8 days in the presence of var-
ying doses of OSM and/or 1 ng/ml LH. [3H]thymidine
was added to the wells during the last 18 h of the culture
period after which the cells were harvested onto glass fibre
filters and the amount of incorporated radioactivity was
determined using a liquid scintillation analyser (Beta
plate, LKB, Turku, Finland).
3β-HSD enzyme histochemistry and cell counts
Interstitial cells isolated from 13-day-old rat testes were
cultured on glass cover-slips in the presence of LH and var-
ying concentrations of OSM in 24 well plates. After 1, 3 or
8 days of culture, 3β-HSD activity was determined in the
cultures according to the method of Loyda et al. [30] with
minor modifications [31]. On each cover-slip a total of at
least 1000 cells was counted (3β-HSD positive plus nega-
tive cells), using a Nikon Optiphot 2 microscope,
equipped with differential interference contrast optics.
The number of blue stained 3β-HSD positive cells was
expressed as percentage of the total number of cells
counted per cover-slip. In control experiments in which
the addition of the substrate 5α-androstane-3β-ol-17-one
was omitted, no blue staining was observed.
Immunohistochemistry
Localization of OSM and OSM type I receptor/LIF receptor
For the localization of OSM interstitial cells were isolated,
plated on glass cover-slips in 24 well plates and cultured
for 3 or 8 days without any additions or in the presence of
LH (1 ng/ml) and/or OSM (10 ng/ml). In case of the local-
ization of OSM and OSM type I receptor/LIF receptor 5
μm thick sections were cut from paraffin embedded testes
of 13-day-old rats. Detection was carried out as described
by De Miguel et al. [27] with minor modifications. Briefly,
cells were fixed in buffered formalin (4% formalin in 0.1.
M PBS), rinsed in 0.01 M PBS, blocked with 10% normal
goat serum and incubated with a polyclonal antibody
against OSM or against OSM type I receptor/LIF receptor
(Santa Cruz Biotechnology, Tebu-Bio, Heerhugowaard,
the Netherlands), both diluted 1:100 in PBS to whichPage 3 of 9
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Netherlands) was added, for 2 h at room temperature
(OSM) or overnight at 4°C). Cells were rinsed with PBS
and incubated with a secondary goat-anti-rabbit bioti-
nylated antibody (Vectastain Kit Elite, Vector Laborato-
ries, Burlingame, CA, USA) diluted 1:100 in PBS/BSA-c for
1 h at room temperature, rinsed and incubated with the
components A (avidin) and B (biotin) (Vector Laborato-
ries) diluted 1:1000 in PBS/BSA-c. Labeling was visualized
using DAB (Sigma). In control experiments the primary
OSM antibody was replaced by normal rabbit serum.
Cells were counter-stained using Mayer's hematoxylin and
mounted with Aquatex (Merck, Darmstadt, Germany).
BrdU and 3β-HSD double labeling
In order to determine whether the 3β-HSD positive cells
were also proliferating, interstitial cells were isolated,
plated on glass cover-slips and cultured for 1 or 3 days
without any additions or in the presence of OSM (10 ng/
ml) and/or LH (1 ng/ml). Three hours before termination
of the experiment BrdU (3.3 μg/ml, Sigma) was added to
the cultures. Cells were fixed in methacarn (60% metha-
nol, 30% chloroform, 10% acetic acid) for 10 min and
then stored at 4°C in 70% alcohol until further process-
ing. BrdU is incorporated in DNA of cells in the S-phase of
the cell cycle and thus is a marker for the proliferative
activity of cells. Immunohistochemical labeling was car-
ried out as described before [32] with minor modifica-
tions. Briefly, cells were pretreated with periodic acid prior
to incubation with the monoclonal antibody against
BrdU (Becton Dickinson Immunocytometry Systems, San
Jose, CA) diluted 1:100 in PBS for 2 h at room tempera-
ture, rinsed and incubated with a peroxidase-conjugated
rabbit-anti-mouse antibody (Sigma) diluted 1:100 in PBS.
Labeling was visualized using DAB (Sigma) enhanced by
nickel that gives a black precipitate. After this cells were
extensively rinsed with PBS and incubated overnight at
4°C with a polyclonal antibody against 3β-HSD (gift from
dr. Mason, Edinburgh, Scotland) as described before [33].
In brief, cells were incubated with the 3β-HSD antibody
(diluted 1:300 in PBS/BSA-c) at room temperature, rinsed
in PBS and incubated with a biotinylated goat-anti-rabbit
antibody (Vector Laboratories) diluted 1:200 in PBS/BSA-
c at room temperature. Next cells were rinsed and incu-
bated with the components A (avidin) and B (biotin)
(Vector Laboratories) diluted 1:1000 in PBS/BSA-c. Labe-
ling was visualized using DAB (Sigma).
Statistical analysis
Data from cultures that had undergone the same treat-
ment in different experiments were combined. Statistical
analysis was performed to test whether the error variance
of the dependent variable was equal across groups using
Levene's test of equality of error variances. Statistical sig-
nificance was assessed by using ANOVA and Bonferroni in
case of multiple comparisons. Differences were consid-
ered to be significant when P < 0.05. The experiments
were performed in triplicate or quadruplicate and
repeated at least three times using different cell prepara-
tions. Data are expressed as mean ± SD.
Results
3H-Thymidine incorporation
OSM, a cytokine locally produced in the testis, has been
shown to stimulate gonocyte proliferation in the neonatal
testis of rats mice and humans [27,34]. In the present
study it was tested whether OSM also has a growth stimu-
lating effect on interstitial cells isolated from 13-day-old
rat testes. Cells were cultured for different periods of time
in the presence of increasing concentrations of OSM
(ranging from 0.01 to 10 ng/ml). Independent of the
length of the culture period, the three lowest concentra-
tions of OSM (0.01, 0.1 and 1 ng/ml) did not significantly
influence [3H]-thymidine incorporation by the interstitial
cells, compared to the control cultures (data not shown).
OSM at a concentration of 10 ng/ml had only a stimulat-
ing effect on [3H]-thymidine incorporation after 8 days of
culture compared to the control cells that were cultured
for the same length of time (Figure 1). Addition of LH to
an OSM dose of 10 ng/ml resulted in an increase of [3H]-
thymidine incorporation after 1 day of culture. After 3
days of culture the level of [3H]-thymidine incorporation
was still higher than in the cultures treated with OSM
alone. By 8 days of culture this effect was no longer seen,
Effects of OSM (10 ng/ml) either alone or in combination with LH (1 ng/ml) o  the prolifer tion of interstitial cells iso-lat d fr m 13-day- ld rat t stes and cultured for 1, 3 or 8 daysFigure 1
Effects of OSM (10 ng/ml) either alone or in combination 
with LH (1 ng/ml) on the proliferation of interstitial cells iso-
lated from 13-day-old rat testes and cultured for 1, 3 or 8 
days. Proliferation was determined by [3H]-thymidine incor-
poration and scintilation counting (see Materials and Meth-
ods). Statistical analysis revealed that there was no significant 
difference among the different experiments. Therefore, the 
results are represented as mean ± SD of three different 
experiments that were combined. Each single experiment 
was carried out in quadruplicate. Differences among groups 
were considered to be significantly different when p < 0.05. a 
– significantly different from control; b – significantly different 
from OSM 10 ng/ml; c – significantly different from LH 1 ng/
ml.
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remained higher when compared to the control cells cul-
tured for 8 days (Figure 1).
3β-HSD enzyme histochemistry and cell counts
The next step was to investigate whether OSM also
affected the differentiation of Leydig stem cells/precursor
cells into progenitor cells. For this experiment the dose of
10 ng/ml OSM was chosen. The percentage of 3β-HSD
positive cells was counted as an indicator of the develop-
ment of Leydig cell progenitors.
In freshly isolated interstitial cell preparations from testes
of 13-day-old rats, the percentage of 3β-HSD positive cells
was less than 2% (data not shown). At this stage the 3β-
HSD positive cell population consisted of a mix of fetal-
type Leydig cells and some newly developed Leydig cell
progenitors. After 1–3 days of culture without any addi-
tions the percentage of 3β-HSD positive cells had
increased about 2-to 4-fold, confirming that these cells
underwent spontaneous differentiation (Figure 2) [18].
Addition of 10 ng/ml OSM to the cells resulted after 8
days of culture in a slight but significant increase in the
percentage of 3β-HSD positive progenitor cells compared
to the control cells cultured for the same length of time
(Figure 2). LH administration resulted throughout the
culture period in higher percentages of 3β-HSD positive
progenitors compared to the controls and the cells cul-
tured in the presence of OSM for the same period of time
(Figure 2). Surprisingly, when OSM and LH were admin-
istered together the percentage of 3β-HSD positive cells
was after 3 and 8 days of culture significantly lower com-
pared to the cells cultured in the presence of LH alone,
though still significantly higher compared to the cells cul-
tured in the presence of OSM alone and the respective
control cultures (Figure 2).
BrdU and 3β-HSD double labeling
The next question that arose was, whether the observed
increases in 3β-HSD positive cells following OSM were
the result of differentiation of stem Leydig cells/precursor
cells into 3β-HSD positive progenitors, or proliferation of
the 3β-HSD positive cells already present in the cultures.
In order to investigate this, interstitial cells were isolated
and cultured for 1 or 3 days in the presence of OSM (10
ng/ml) or LH alone, or in the presence of the combination
of OSM and LH. Before terminating the experiments, cells
were incubated with BrdU (for details see Materials and
Methods) to determine the proliferative activity of the
cells. Cells were double labeled with antibodies against
BrdU and 3β-HSD. The results of this experiment showed
that the percentage of double labeled cells following OSM
treatment alone or in combination with LH was neither
after 1 day nor after 3 days of culture significantly different
from zero, and also did not differ significantly from the
controls (day 1: 0.1 ± 0.1 (OSM), 0.2 ± 0.2 (LH + OSM),
0.1 ± 0.1 (control); day 3: 0 (OSM), 0.9 ± 1.3 (LH + OSM),
0.1 ± 0.1 (control). After 8 days of culture no BrdU/3β-
HSD double stained positive cells could be detected under
any of the culture conditions. As has been reported previ-
ously, LH alone did not influence the proliferative activity
of the 3β-HSD positive cells under the present culture con-
ditions (18).
OSM and OSM type I receptor/LIF receptor 
immunohistochemistry
De Miguel and colleagues [27,29] have reported that in
the developing and adult testis interstitial cells, presuma-
bly Leydig cells, stained positively with an antibody
against OSM. In the present study the nature of the OSM
positive cells was confirmed by immunohistochemical
staining of testis sections derived from adult rats treated
with the Leydig cell toxicant ethane dimethyl sulphonate
(EDS). This drug specifically destroys Leydig cells in the
adult testis, a process followed by the formation of a com-
plete new population of Leydig cells [e.g. [35]]. This
regeneration process has many similarities with the devel-
opment of the adult-type Leydig cell population in the
prepubertal rat [36]. Eight days after EDS administration
at a point in time when Leydig cells had not yet started to
repopulate the testis, no OSM positive interstitial cells
could be detected in the interstitial compartment (Figure
Effect of OSM (10 ng/ml) either alone or in combination with LH (1 ng/ml) on the pres nce of 3β-HSD positive Leydig cellprogenitorsFigure 2
Effect of OSM (10 ng/ml) either alone or in combination with 
LH (1 ng/ml) on the presence of 3β-HSD positive Leydig cell 
progenitors. Interstitial cells were isolated from 13-day-old 
rat testes and cultured for 1, 3 or 8 days. The presence of 
3β-HSD was determined by enzyme histochemistry or 
immunohistochemistry using a polyclonal antibody against 
3β-HSD (for details see Materials and Methods). Statistical 
analysis revealed that there was no significant difference 
among the different experiments and thus the results are 
presented as mean ± SD of three different experiments that 
were combined. Each single experiment was carried out 
either in duplicate, triplicate or quadruplicate. Differences 
among groups were considered to be significantly different 
when p < 0.05. a – significantly different from control; b – sig-
nificantly different from OSM 10 ng/ml; c – significantly differ-
ent from LH 1 ng/ml.
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the study by De Miguel et al. [27] were indeed Leydig cells.
Analysis of cells cultured for 3 or 8 days in the presence of
LH and stained immunohistochemically for the presence
of OSM, showed a significant increase in the percentage of
OSM positive cells when compared to the untreated con-
trols cultured for the same periods of time (Figure 3B, C).
When OSM was given together with LH the stimulating
effect of LH was partially inhibited (Figure 3B).
Immunohistochemical staining for the presence of OSM
type I receptor/LIF receptor of paraffin embedded sections
of testes from 13-day-old rats revealed that in the intersti-
tium this receptor was present on spindle-shaped peritu-
bularly located stem Leydig cells/precursor cells, as well as
on progenitor cells and fetal-type Leydig cells (Figure 4).
The number of positively stained macrophages was very
small due to the low numbers of macrophages present in
the 13-day-old rat testis (not shown). Within the seminif-
erous tubules the spermatogonia stained faintly positive
(Figure 4). No staining was observed in the Sertoli cells,
presumably because the amount of antigen present was
below the detection limit of the immunohistochemical
assay.
Discussion
Although Leydig cells have been shown to possess LIF
receptors [37] it is not known whether these cells or their
stem cells/precursor cells express functional OSM recep-
tors and are thus able to respond to OSM released by for
instance Sertoli cells. The present study is the first to dem-
onstrate that these stem cells/progenitor cells express the
LIF receptor/OSM type 1 receptor and that OSM by bind-
ing to this receptor can affect the formation of Leydig cell
progenitors in vitro. Nevertheless, the effects of OSM on
progenitor development seem to be contradictory,
depending on the presence of LH. When interstitial cells
were cultured in the presence of OSM for a prolonged
period of time, progenitor formation was increased by
approximately 40%, due to differentiation of stem Leydig
cells/precursor cells. However, when the cells were cul-
tured in the presence of the combination of OSM and LH,
OSM appeared to significantly inhibit the LH stimulated
formation of progenitor cells by about 35%.
Immunohistochemical labelling for the presence of OSM in vivo and in vitroFigure 3
Immunohistochemical labelling for the presence of OSM in vivo and in vitro. A) Section of the testis of a rat 8 days after EDS 
administration. All Leydig cells have disappeared from the interstitium. Under these conditions no OSM positive cells could be 
detected by immunohistochemistry; B) Interstitial cell were isolated from testes of 13-day-old rats and cultured for 3 or 8 days 
without any additions or in the presence of 10 ng/ml OSM and/or 1 ng/ml LH (for more details see Materials and Methods). 
Percentage of OSM positive cells in culture determined under the indicated culture conditions. The experiment was carried 
out in quadruplicate. Values are represented as mean ± SD; statistical analysis was carried by comparing the treated cultures 
with their respective controls. Means were considered to be significantly different at p < 0.05 (indicated by (a)). C) Cells cul-
tured in the presence of LH for 8 days and immunohistochemically stained with an antibody against OSM. Some positively 
stained cells are indicated by arrows. Scale bar in (A) represents 21 μm, in (C) 20 μm.
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Reproductive Biology and Endocrinology 2007, 5:43 http://www.rbej.com/content/5/1/43We have reported recently that when testicular interstitial
cells were isolated from 13-day-old rats and cultured, a
small subpopulation of stem Leydig cells/precursor cells
can develop into Leydig cell progenitors autonomously
within 3 days after plating, independent of the immediate
presence of LH [18]. Since OSM is highly expressed in the
fetal and neonatal rat testis, we hypothesized that OSM
may be a candidate factor involved in the autonomous
formation of progenitor cells. This hypothesis is, however,
not supported by the results of the present study, since it
takes between 4 and 8 days for OSM to augment the
number of progenitor cells, making it unlikely that OSM
plays a role in the autonomous formation of progenitor
cells.
Incubation of interstitial cells with the combination of LH
and OSM, did not lead to a synergistic effect on progenitor
formation. On the contrary, the augmenting effect of LH
on the differentiation of stem Leydig cells/precursor cells
into 3β-HSD progenitor cells after 3 and 8 days of culture
was partially inhibited by OSM. LH acts though activation
of a G-protein coupled receptor inducing the formation of
the second messenger cAMP, in general followed by acti-
vation of PKA, tyrosine phosphorylation and activation of
Ras [38]. OSM binding to its receptor complex, the type I
or type II OSM receptor, activates the Janus tyrosine
kinases (Jaks) and the activated Jaks in turn activate down-
stream pathways such as SHP-2 tyrosine phosphatase and
STAT3 [39]. How these two signal transduction pathways
communicate with each other, resulting in the partial
inhibition of LH stimulated progenitor formation is at
present unknown.
Several studies have reported on a possible physiological
role of OSM in testicular development. In co-cultures of
rat Sertoli cells and gonocytes human recombinant OSM
appeared to stimulate gonocyte proliferation [27], while
in mouse derived neonatal testicular cell cultures, recom-
binant mouse OSM was shown to enhance Sertoli cell
proliferation [34]. Furthermore, Sertoli cells have been
shown to release an OSM-like protein, implicating that
under in vivo conditions locally produced OSM may
affect both neonatal Sertoli cell proliferation and be
involved in the initiation of spermatogenesis [27]. Over-
expression of OSM in transgenic mice, on the other hand,
leads to developmental abnormalities and infertility due
to the absence of developing spermatocytes [40]. These
authors further hypothesize that in order for OSM to exert
a regulatory role on early testicular development, its syn-
thesis and release need to be tightly regulated. The present
study extends these observations by showing that OSM
does not only affect Sertoli cells and germ cells in the neo-
natal testis, but possibly also plays a role in the formation
of the adult Leydig cell population by keeping the stimu-
lating effect of LH on Leydig cell progenitor formation in
abeyance.
The combination of LH plus OSM not only affected pro-
genitor formation but also induced an enhancement of
[3H]-thymidine incorporation compared to the control
group, especially after 1 day of culture. Since the percent-
age of 3β-HSD/BrdU double labeled cells had not
increased under these conditions, it is postulated that
these proliferating cells are not Leydig cell progenitors.
However, since Leydig cells and their precursors are the
only cell types in the interstitium that express functional
LH receptors [18], the effects on cell proliferation induced
by the combination of LH and OSM, are most likely medi-
ated indirectly. Possibly, precursor cells and/or progenitor
cells are stimulated to release (growth) factors that affect
the proliferative activity of other cells present in the cul-
tures.
Several studies have reported the presence of OSM posi-
tive cells in the testicular interstitium in different species
such as rat, mouse, monkey and human. These authors
suggested that the OSM expressing cells in the interstitium
may be Leydig cells [27,29,41]. In the present study
immunohistochemical analysis revealed that the effects of
Immunohistochemical labelling for the presence of LIF-R in the testis of 13-day-o d rats (A-C)Figure 4
Immunohistochemical labelling for the presence of LIF-R in 
the testis of 13-day-old rats (A-C). Faint brown staining for 
the presence of OSM type I receptor/LIF receptor is present 
in a cluster of fetal-type Leydig cells (A; asterisk). The staining 
is much stronger in stem Leydig cells/precursor cells identi-
fied by their spindle-shaped nucleus, located in close vicinity 
of the basal membrane of the seminiferous tubules (A, B; 
filled arrows) and in Leydig cell progenitors identified by their 
oval nucleus which are either found close to the seminiferous 
tubules (A, B) or blood vessels (C; arrowhead). Staining in 
spermatogonia was faint (B, C; open arrow). (D) Control in 
which the first antibody was replaced by rabbit serum. Scale 
bar represents 11 μm.
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Reproductive Biology and Endocrinology 2007, 5:43 http://www.rbej.com/content/5/1/43OSM and/or LH on the percentage of OSM positive cells
showed a consistent similarity to the effects of these fac-
tors on the percentage of 3β-HSD positive progenitor
cells, implicating that the OSM positive cells may indeed
be Leydig cells. This was confirmed by treatment of rats
with the Leydig cell toxicant EDS, which specifically
destroys Leydig cells in the adult testis [36]. Following
EDS administration, no cells positively stained for the
presence of OSM could be detected in the interstitium by
immunohistochemistry.
Many of the described effects of OSM overlap with the
effects of LIF a highly pleiotropic cytokine. As indicated
above, OSM can bind to the LIF receptor β subunit dimer-
ized with gp130, the so-called type I OSM receptor as well
as to the type II OSM receptor, consisting of a dimer of
gp130 and the OSM-specific receptor β subunit (OSMR)
[25,26]. Sertoli cells but also Leydig cells and spermatogo-
nia, have been reported to express functional LIF receptors
[28,42], which may explain why targeted disruption of the
type II OSM receptor [40], did not lead to infertility. On
the other hand, in a recent study Kanatsu-Shinohara and
colleagues (2007) showed that while LIF enhanced the
formation of germ cell colonies in neonatal mouse testis
cultures, OSM failed to exert this effect, suggesting that
OSM can not replace LIF in all cases and that at least in
part these molecules have differential effects on spermato-
gonial development [43].
Conclusion
Taken together, the results of the present study suggest
that locally produced OSM is not only involved in the reg-
ulation of Sertoli cell proliferation and the start of sperma-
togenesis, but may also play a role in the regulation of
Leydig cell progenitor formation by keeping the stimulat-
ing effects of LH on this process in abeyance.
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